Kelvin Brockbank to Heart Valves
This is a "connection" page, showing publications Kelvin Brockbank has written about Heart Valves.
Connection Strength
3.996
-
Vitrification of Heart Valve Tissues. Methods Mol Biol. 2021; 2180:593-605.
Score: 0.633
-
Vitrification of heart valve tissues. Methods Mol Biol. 2015; 1257:399-421.
Score: 0.417
-
Xeno-immunogenicity of ice-free cryopreserved porcine leaflets. J Surg Res. 2015 Feb; 193(2):933-41.
Score: 0.411
-
Characterization of a simplified ice-free cryopreservation method for heart valves. Cell Tissue Bank. 2013 Jun; 14(2):195-203.
Score: 0.350
-
Ice-free cryopreservation of heart valve allografts: better extracellular matrix preservation in vivo and preclinical results. Cell Tissue Bank. 2012 Dec; 13(4):663-71.
Score: 0.339
-
Allogeneic heart valve storage above the glass transition at -80?C. Ann Thorac Surg. 2011 Jun; 91(6):1829-35.
Score: 0.324
-
Ice Control during Cryopreservation of Heart Valves and Maintenance of Post-Warming Cell Viability. Cells. 2022 06 07; 11(12).
Score: 0.175
-
Interstitial ice formation in cryopreserved homografts: a possible cause of tissue deterioration and calcification in vivo. J Heart Valve Dis. 2000 Mar; 9(2):200-6.
Score: 0.149
-
Effects on human heart valve immunogenicity in vitro by high concentration cryoprotectant treatment. J Tissue Eng Regen Med. 2018 02; 12(2):e1046-e1055.
Score: 0.124
-
Allograft Heart Valves: Current Aspects and Future Applications. Biopreserv Biobank. 2017 Apr; 15(2):148-157.
Score: 0.121
-
Comparison and evaluation of biomechanical, electrical, and biological methods for assessment of damage to tissue collagen. Cell Tissue Bank. 2016 Sep; 17(3):531-9.
Score: 0.114
-
Influence of whole heart postprocurement cold ischemia time upon cryopreserved heart valve viability. Transplant Proc. 1993 Dec; 25(6):3188-9.
Score: 0.097
-
Cytotoxicity of amphotericin B for fibroblasts in human heart valve leaflets. Cryobiology. 1993 Feb; 30(1):19-24.
Score: 0.091
-
Development of a simplified ice-free cryopreservation method for heart valves employing VS83, an 83% cryoprotectant formulation. Biopreserv Biobank. 2012 Dec; 10(6):479-84.
Score: 0.090
-
Issues surrounding the preservation of viable allograft heart valves. J Med Eng Technol. 1992 Jan-Feb; 16(1):34-8.
Score: 0.085
-
The correlation between improved cellular viability and clinical performance in 5,000 cryopreserved human heart valves. ASAIO Trans. 1991 Jul-Sep; 37(3):M355-6.
Score: 0.082
-
Guidance for removal of fetal bovine serum from cryopreserved heart valve processing. Cells Tissues Organs. 2011; 193(4):264-73.
Score: 0.079
-
The performance of ice-free cryopreserved heart valve allografts in an orthotopic pulmonary sheep model. Biomaterials. 2010 Jul; 31(20):5306-11.
Score: 0.076
-
Cell viability in fresh, refrigerated, and cryopreserved human heart valve leaflets. Ann Thorac Surg. 1990 May; 49(5):848-9.
Score: 0.075
-
Optimized preservation of extracellular matrix in cardiac tissues: implications for long-term graft durability. Ann Thorac Surg. 2007 May; 83(5):1641-50.
Score: 0.061
-
Impact of T-cell-mediated immune response on xenogeneic heart valve transplantation: short-term success and mid-term failure. Eur J Cardiothorac Surg. 2018 04 01; 53(4):784-792.
Score: 0.033
-
Simultaneous monitoring of different vitrification solution components permeating into tissues. Analyst. 2018 Jan 15; 143(2):420-428.
Score: 0.032
-
Effects of storage temperature on viable bioprosthetic heart valves. Cryobiology. 1992 Oct; 29(5):537-42.
Score: 0.022
-
Measurement of postcryopreservation viability. J Card Surg. 1987 Mar; 2(1 Suppl):145-51.
Score: 0.015